Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease

Katharina Mayer, MD; Ralph Hein-Rothweiler, MD; Stefanie Schüpke, MD; Marion Janisch, MD;
Isabell Bernlochner, MD; Gjin Ndrepepa, MD; Dirk Sibbing, MD; Tommaso Gori, MD; Oliver Borst, MD;
Stefan Holdenrieder, MD; Danny Kupka, MD; Tobias Petzold, MD; Christian Bradaric, MD; Rainer Okrojek, MD; David M. Leistner, MD; Tobias D. Trippel, MD; Thomas Münzel, MD; Ulf Landmesser, MD; Burkert Pieske, MD; Andreas M. Zeiher, MD; Meinrad P. Gawaz, MD; Alexander Hapfelmeier, DSc; Karl-Ludwig Laugwitz, MD; Heribert Schunkert, MD; Adnan Kastrati, MD; Steffen Massberg, MD